Showing results 1 to 6 of 6
Title | Author(s) | Issue Date | |
---|---|---|---|
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer Journal:International Journal of Molecular Sciences | 2022 | ||
KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer Journal:Clinical and Translational Medicine | 2021 | ||
Overexpression of BQ323636.1 contributes to anastrozole resistance in AR+ve/ER+ve breast cancer Journal:Journal of Pathology | 9-Aug-2023 | ||
2022 | |||
Repurposing hyperpolarization‐activated cyclic nucleotide‐gated channels as a novel therapy for breast cancer Journal:Clinical and Translational Medicine | 2021 | ||
13-Apr-2023 |